ClinicalTrials.gg
Drug

Setmelanotide clinical trials

Also written RM-493 and Imcivree.

studies test it
25
open now
3
in phase 3
10
first study started
2012

How each study uses setmelanotide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the setmelanotide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Nov 2020 · IMCIVREE · NDA 213793 (FDA, Drugs@FDA)
European Union
16 Jul 2021 · Imcivree · EMEA/H/C/005089 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Setmelanotide
23

Brand

Imcivree
5

Development codes

RM-493
15

Studies by the year they started

25 studies that test it; most in 2021 (4)

Studies that test setmelanotide, by start year
YearStudies
20121
20132
20141
20152
20173
20183
20201
20214
20222
20232
20241
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
11
Phase 3
10
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 22 · Other 3

Rhythm Pharmaceuticals, Inc. (22) · Massachusetts General Hospital (1) · Tom Hühne (1) · Charite University, Berlin, Germany (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test setmelanotide, phase 3 first.

Studies

Open first, then newest update. How each study uses setmelanotide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test setmelanotide →

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call setmelanotide · ClinicalTrials.gg INT006260

  • MeSH (NLM) C579663setmelanotideOne source ClinicalTrials.gov
  • UNII (FDA) N7T15V1FUYSETMELANOTIDEConfirmed FDA, Wikidata
  • RxNorm 2469247One source FDA
  • Wikidata Q21098917setmelanotideConfirmed FDA, Wikidata
  • NCI Thesaurus C152349SetmelanotideOne source FDA
  • DrugBank DB11700One source Wikidata

Also registered as setmelanotide acetate (UNII 224I1W20I7 · RxNorm 2469248).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.